Earlier in the week, I wrote about a cancer vaccine treatment that Stanford pathologist Edgar Engleman, MD, developed in the early 90s. As expected, the FDA gave the vaccine, called Provenge, the thumbs up today; according to Dow Jones (subscription required), the agency approved Provenge for patients with advanced prostate cancer who have failed hormone therapy treatment.
Popular posts
How viruses like the coronavirus can steal our sense of smell
Stanford ENT surgeon discusses how viruses cause a loss of sense of smell, and what you should do about it in the era of the coronavirus pandemic.
Stanford medical student’s tweet about blueberry pickers’ wages goes viral
Incoming medical student and blueberry picker Gianna Nino caught the attention of the media when she tweeted about farmworker wages.